Article Versions Notes

Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr., Kobayashi T, Koizumi T, et al. In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination. Vaccines. 2019; 7(3):120. https://doi.org/10.3390/vaccines7030120

Shimodaira, Shigetaka, Ryu Yanagisawa, Terutsugu Koya, Koichi Hirabayashi, Yumiko Higuchi, Takuya Sakamoto, Misa Togi, Tomohisa Kato, Jr., Takashi Kobayashi, Tomonobu Koizumi, and et al. 2019. "In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination" Vaccines 7, no. 3: 120. https://doi.org/10.3390/vaccines7030120

Shimodaira, S., Yanagisawa, R., Koya, T., Hirabayashi, K., Higuchi, Y., Sakamoto, T., Togi, M., Kato, T., Jr., Kobayashi, T., Koizumi, T., Koido, S., & Sugiyama, H. (2019). In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination. Vaccines, 7(3), 120. https://doi.org/10.3390/vaccines7030120